Cleared Traditional

K041434 - C3 AND LIFEGARD ICG IMPEDANCE CARDIOGRA...

K041434 is the FDA 510(k) clearance for C3 AND LIFEGARD ICG IMPEDANCE CARDIOGRA... by Analogic Corp.. It is a Class 2 Cardiovascular device (product code DSB) cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K041434 · Analogic Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2004
Decision
70d
Days
Class 2
Risk

K041434 is an FDA 510(k) clearance for the C3 AND LIFEGARD ICG IMPEDANCE CARDIOGRAPHY MONITORS. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Analogic Corp. (Peabody, US). The FDA issued a Cleared decision on August 6, 2004 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Analogic Corp. devices

Submission Details

510(k) Number K041434 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 2004
Decision Date August 06, 2004
Days to Decision 70 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 125d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSB Plethysmograph, Impedance

All 16
Devices cleared under the same product code (DSB) and FDA review panel - the closest regulatory comparables to K041434.
ReDS System
K180479 · Sensible Medical Innovations , Ltd. · Feb 2019
Cardiovascular Analzyer
K172431 · Physiowave, Inc. · Mar 2018
ECOM ENDOTRACHEAL CARDIAC OUTPUT MONITOR SYSTEM
K131765 · Conmed Corporation · Dec 2013
ICG MODULE
K010164 · General Electric Medical Systems Information Techn · Apr 2001
PERCUPUMP II WITH EDA
K974621 · E-Z-Em, Inc. · Jan 1998
PERCUPUMP II WITH EDA
K961845 · E-Z-Em, Inc. · Jan 1997